More: Medscape Perspectives on the American Psychiatric Association (APA) 161st Annual Meeting

APA 2008: ADHD CME/CE

May 3 - 8, 2008, Washington, DC

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the American Psychiatric Association. Conference news does not receive grant support and is produced independently.

Release Date: June 20, 2008; Valid for credit through June 20, 2009

Credits Available
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.25 nursing contact hours (1.0 contact hours are in the area of pharmacology);
Pharmacists - 1.25 ACPE continuing education credits for pharmacists (0.125 CEUs)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

  1. Child and Adolescent ADHD: An Update on PharmacotherapyPaul G. Hammerness, MD; Alisa R. Gutman, PhD
  2. Pharmacotherapy of Adult ADHDCraig B.H. Surman, MD
  3. Comorbidity in Adult ADHDCraig B.H. Surman, MD

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Psychiatric Association. These materials and the related activity are not sanctioned by the American Psychiatric Association or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Shire
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Identify common psychiatric conditions that occur comorbidly with ADHD
  2. Describe emerging stimulant and nonstimulant agents for treating ADHD in adults and children.
  3. Discuss new data related to safety and tolerability of emerging stimulant and nonstimulant agents for treating ADHD in adults and children.
Authors and Disclosures

Craig B.H. Surman, MD
Disclosure: Craig B.H. Surman, MD, has disclosed that he receives/d support for clinical research from, is/has been a speaker for, or is/has been on the advisory board for, or is/has received support for educational writing from the following pharmaceutical companies: Shire, Eli Lilly, McNeil, Abbott, New River Pharmaceuticals, Cephalon, Janssen, Merck, Novartis, Takeda. Other sources of research support include The Hilda and Preston Davis Foundation, NIMH, and NIDA.


Paul G. Hammerness, MD
Disclosure: Paul G. Hammerness, MD, has disclosed that he has received grants for clinical research and served on the speakers’ bureau for Shire.


Alisa R. Gutman, PhD
Disclosure: Alisa R. Gutman, PhD, has disclosed no relevant financial relationships.


Priscilla Scherer, RN
Disclosure: Priscilla Scherer, RN, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.25 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

 
ACPE logoMedscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medscape designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) (Universal Program Number 461-000-08-021-H01-P).

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.